IQ change over time in schizophrenia and healthy individuals: A meta-analysis

Schizophrenia Research

Volumn 146, Issue 1-3, 2013, Pages 201-208

  Hedman, Anna M ^a   van Haren, Neeltje E M ^a   van Baal, Caroline G M ^a   Kahn, René S ^a   Hulshoff Pol, Hilleke E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

IQ; Longitudinal; Meta analysis; Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; NEUROLEPTIC AGENT;

ARTICLE; COGNITIVE DEFECT; COHORT ANALYSIS; EFFECT SIZE; HUMAN; INTELLECTUAL IMPAIRMENT; INTELLIGENCE; INTELLIGENCE QUOTIENT; INTELLIGENCE TEST; MATHEMATICAL COMPUTING; MENTAL PERFORMANCE; ONSET AGE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCHIZOPHRENIA; SYSTEMATIC REVIEW;

COGNITION DISORDERS; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; INTELLIGENCE; INTELLIGENCE TESTS; MALE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84875936861     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.01.027     Document Type: Article

References (56)

1. Albus M., Hubmann W., Mohr F., Hecht S., Hinterberger-Weber P., Seitz N.N., Küchenhoff H. Neurocognitive functioning in patients with first-episode schizophrenia: results of a prospective 5-year follow-up study. Eur. Arch. Psychiatry Clin. Neurosci. 2006, 256(7):442-451.
2. Amminger G.P., Schlögelhofer M., Lehner T., Looser Ott S., Friedrich M.H., Aschauer H.N. Premorbid performance IQ deficit in schizophrenia. Acta Psychiatr. Scand. 2000, 102(6):414-422.
3. Aylward E., Walker E., Bettes B. Intelligence in schizophrenia: meta-analysis of the research. Schizophr. Bull. 1984, 10(3):430-459.
4. Bilder R.M., Degreef G., Pandurangi A.K., Rieder R.O., Sackeim H.A., Mukherjee S. Neuropsychological deterioration and CT scan findings in chronic schizophrenia. Schizophr. Res. 1988, 1(1):37-45.
5. Bilder R.M., Lipschutz-Broch L., Reiter G., Geisler S.H., Mayerhoff D.I., Lieberman J.A. Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration. Schizophr. Bull. 1992, 18(3):437-448.
6. Bilder R.M., Reiter G., Bates J., Lencz T., Szeszko P., Goldman R.S., Robinson D., Lieberman J.A., Kane J.M. Cognitive development in schizophrenia: follow-back from the first episode. J. Clin. Exp. Neuropsychol. 2006, 28(2):270-282.
7. Borenstein M., Rothstein H. Comprehensive Meta-analysis: A Computer Program for Research Synthesis 1999, BioStat, Inc, Englewood.
8. Carter J.W., Parnas J., Urfer-Parnas A., Watson J., Mednick S.A. Intellectual functioning and the long-term course of schizophrenia-spectrum illness. Psychol. Med. 2010, 22(Sep):1-15.
9. Caspi A., Reichenberg A., Weiser M., Rabinowitz J., Kaplan Z., Knobler H., Davidson-Sagi N., Davidson M. Cognitive performance in schizophrenia patients assessed before and following the first psychotic episode. Schizophr. Res. 2003, 65(2-3):87-94.
10. Catron D.W., Thompson C.C. Test-retest gains in WAIS scores after four retest intervals. J. Clin. Psychol. 1979, 35(2):352-357.
11. Censits D.M., Ragland J.D., Gur R.C., Gur R.E. Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study. Schizophr. Res. 1997, 11(3):289-298.
12. Cervellione K.L., Birdick K.E., Cottone J.D., Rhinewine J.P., Kumra S. Neurocognitive deficits in adolescents with schizophrenia: longitudinal stability and predictive utility for short-term functional outcome. J. Am. Acad. Child Adolesc. Psychiatry 2007, 46(7):867-878.
13. Cohen J. Statistical Power Analysis for the Behavioral Sciences 1988, Lawrence Erlbaum Associates, Hillsdale.
14. Crespo-Facorro B., Rodríguez-Sánchez J.M., Pérez-Iglesias R., Mata I., Ayesa R., Ramirez-Bonilla M., Martínez-Garcia O., Vázquez-Barquero J.L. Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison. J. Clin. Psychiatry 2009, 70(5):717-729.
15. DerSimonian R., Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp. Clin. Trials 2007, 28(2):105-114.
16. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7(3):177-188.
17. Dickinson D., Ragland J.D., Gold J.M., Gur R.C. General and specific cognitive deficits in schizophrenia: Goliath defeats David?. Biol. Psychiatry 2008, 64(9):823-827.
18. Dickson H., Laurens K.R., Cullen A.E., Hodgins S. Meta-analyses of cognitive and motor function in youth aged 16years and younger who subsequently develop schizophrenia. Psychol. Med. 2011, 6(Sep):1-13.
19. Flynn J.R. WAIS-III and WISC-III IQ gains in the United States from 1972 to 1995: how to compensate for obsolete norms. Percept. Mot. Skills 1998, 86:1231-1239.
20. Fowler T., Zammit S., Owen M.J., Rasmussen F. A population-based study of shared genetic variation between premorbid IQ and psychosis among male twin pairs and sibling pairs from Sweden. Arch. Gen. Psychiatry 2012, 69:460-466.
21. Frangou S., Hadjulis M., Vourdas A. The Maudsley early onset schizophrenia study: cognitive function over a 4-year follow-up period. Schizophr. Bull. 2008, 34(1):52-59.
22. Fuller R., Nopoulos P., Arndt S., O'Leary D., Ho B.C., Andreasen N.C. Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance. Am. J. Psychiatry 2002, 159(7):1183-1189.
23. Gold S., Arndt S., Nopoulos P., O'Leary D.S., Andreasen N.C. Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. Am. J. Psychiatry 1999, 156(9):1342-1348.
24. Granholm E., Link P., Fish S., Kraemer H., Jeste D. Age-related practice effects across longitudinal neuropsychological assessments in older people with schizophrenia. Neuropsychology 2010, 24(5):616-624.
25. Harvey P.D., Reichenberg A., Bowie C.R., Patterson T.L., Heaton R.K. The course of neuropsychological performance and functional capacity in older patients with schizophrenia: influences of previous history of long-term institutional stay. Biol. Psychiatry 2010, 67(10):933-939.
26. Heaton R.K., Gladsjo J.A., Palmer B.W., Kuck J., Marcotte T.D., Jeste D.V. Stability and course of neuropsychological deficits in schizophrenia. Arch. Gen. Psychiatry 2001, 58(1):24-32.
27. Hedges L.V., Olkin I. Statistical Methods for Meta-analysis 1985, Academic Press, New York.
28. Hedman A.M., van Haren N.E.M., van Baal G.C.M., Brans R.G.H., Hijman R., Kahn R.S., Hulshoff Pol H.E. Is there change in IQ in chronically ill schizophrenia patients? A longitudinal study in twins discordant for schizophrenia. Psychol. Med. 2012, 42(12):2535-2541.
29. Heinrichs R.W., Zakzanis K.K. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998, 12(3):426-445.
30. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327(7414):557-560.
31. Hoff A.L., Sakuma M., Wieneke M., Horon R., Kushner M., DeLisi L.E. Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia. Am. J. Psychiatry 1999, 156(9):1336-1341.
32. Hoff A.L., Svetina C., Shields G., Stewart J., DeLisi L.E. Ten year longitudinal study of neuropsychological functioning subsequent to a first episode of schizophrenia. Schizophr. Res. 2005, 78(1):27-34.
33. 2 index?. Psychol. Methods 2006, 11(2):193-206.
34. Hulshoff Pol H.E., Kahn R.S. What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophr. Bull. 2008, 34(2):354-366.
35. Jepsen J.R., Fagerlund B., Pagsberg A.K., Christensen A.M., Hilker R.W., Nordentoft M., Mortensen E.L. Course of intelligence deficits in early onset, first episode schizophrenia: a controlled, 5-year longitudinal study. Eur. Child Adolesc. Psychiatry 2010, 19(4):341-351.
36. Kaufman A.S. WAIS-III IQs, Horn's theory, and generational changes from young adulthood to old age. Intelligence 2001, 29(2):131-167.
37. Kraepelin E. Psychiatrie. Ein kurzes Lehrbuch für Studierende und Ärtze 1893, 435-445. 4e Auflage.
38. Kremen W.S., Buka S.L., Seidman L.J., Goldstein J.M., Koren D., Tsuang M.T. IQ decline during childhood and adult psychotic symptoms in a community sample: a 19-year longitudinal study. Am. J. Psychiatry 1998, 155(5):672-677.
39. Leeson V.C., Barnes T.R., Harrison M., Matheson E., Harrison I., Mutsatsa S.H., Ron M.A., Joyce E.M. The relationship between IQ, memory, executive function, and processing speed in recent-onset psychosis: 1-year stability and clinical outcome. Schizophr. Bull. 2010, 36(2):400-409.
40. Leeson V.C., Sharma P., Harrison M., Ron M.A., Barnes T.R., Joyce E.M. IQ trajectory, cognitive reserve, and clinical outcome following a first episode of psychosis: a 3-year longitudinal study. Schizophr. Bull. 2011, 37(4):768-777.
41. Lipsey M.W., Wilson D.B. The way in which intervention studies have "personality" and why it is important to meta-analysis. Eval. Health Prof. 2001, 24(3):236-254.
42. Lubin A., Gieseking C.F., Williams H.L. Direct measurement of cognitive deficit in schizophrenia. J. Consult. Psychol. 1962, 26(Apr):139-143.
43. McCaffrey R.J., Duff K., Westervelt H.J. Practitioner's Guide to Evaluating Change with Neuropsychological Assessment Instruments 2000, Kluwer Academic/Plenum Press, New York.
44. Orwin R.G. A fail-safe N for effect size in meta-analysis. J. Educ. Stat. 1983, 8(2):157-159.
45. Pantelis C., Yücel M., Wood S.J., Velakoulis D., Sun D., Berger G., Stuart G.W., Yung A., Phillips L., McGorry P.D. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr. Bull. 2005, 31(3):672-696.
46. Rabbitt P., Lunn M., Wong D., Cobain M. Age and ability affect practice gains in longitudinal studies of cognitive change. J. Gerontol. B Psychol. Sci. Soc. Sci. 2008, 63(4):235-240.
47. Ramsden S., Richardson F.M., Josse G., Thomas M.S., Ellis C., Shakeshaft C., Seghier M.L., Price C.J. Verbal and non-verbal intelligence changes in the teenage brain. Nature 2011, 479(7371):113-116.
48. Rapport L.J., Brines D.B., Axelrod B.N., Theisen M.E. Full scale IQ as mediator of practice effects: the rich get richer. Clin. Neuropsychol. 1997, 11(4):375-380.
49. Reichenberg A., Weiser M., Rapp M.A., Rabinowitz J., Caspi A., Schmeidler J., Knobler H.Y., Lubin G., Nahon D., Harvey P.D., Davidson M. Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. Arch. Gen. Psychiatry 2005, 62(12):1297-1304.
50. Reichenberg A., Weiser M., Caspi A., Knobler H.Y., Lubin G., Harvey P.D., Rabinowitz J., Davidson M. Premorbid intellectual functioning and risk of schizophrenia and spectrum disorders. J. Clin. Exp. Neuropsychol. 2006, 28(2):193-207.
51. Rosenthal R. Meta-analytic Procedures for Social Research 1991, Sage Publications, London.
52. Seidman L.J., Buka S.L., Goldstein J.M., Tsuang M.T. Intellectual decline in schizophrenia: evidence from a prospective birth cohort 28year follow-up study. J. Clin. Exp. Neuropsychol. 2006, 28(2):225-242.
53. Szöke A., Trandafir A., Dupont M.E., Méary A., Schürhoff F., Leboyer M. Longitudinal studies of cognition in schizophrenia: meta-analysis. Br. J. Psychiatry 2008, 192(4):248-257.
54. Toulopoulou T., Picchioni M., Rijsdijk F., Hua-Hall M., Ettinger U., Sham P., Murray R. Substantial genetic overlap between neurocognition and schizophrenia: genetic modeling in twin samples. Arch. Gen. Psychiatry 2007, 64(12):1348-1355.
55. Woodberry K.A., Giuliano A.J., Seidman L.J. Premorbid IQ in schizophrenia: a meta-analytic review. Am. J. Psychiatry 2008, 165(5):579-587.
56. Zammit S., Allebeck P., David A.S., Dalman C., Hemmingsson T., Lundberg I., Lewis G. A longitudinal study of premorbid IQ Score and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses. Arch. Gen. Psychiatry 2004, 61(4):354-360.